|
| Exchange Received Time 29/05/2018 20:02:40 Exchange Disseminated Time 29/05/2018 20:02:44 Time Taken 00:00:04 | In compliance with Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with corresponding circulars and notifications issued thereunder, it is hereby informed to you that the Board of Directors of Glenmark Pharmaceuticals Limited at its meeting held on May 29, 2018, approved the draft share purchase agreement to acquire 100% stake in Zorg Laboratories Private Limited (Zorg) for an aggregate consideration of Rs. 5 lacs before adjustments and subject to legal and financial due diligence.
You are requested to take the same on record.
|
|
|